[23] [24] The MHRA advises testing for B12 deficiency if symptoms or signs develop in patients taking metformin, and considering periodic monitoring in those at risk
Patients with absorption conditions or strict plant-based diets may not reach adequate levels through food alone, making injections at GLOW a reliable alternative
NNMT as Target (Kraus et al., 2014): NNMT knockdown in white adipose tissue and liver protected against diet-induced obesity by increasing cellular energy expenditure
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
Comparison With Other Research Compounds SLU-PP-332 versus mitochondrial and metabolic compounds SLU-PP-332 versus other ERR modulators Consequently, Direct potency comparisons require caution because assay design, receptor expression, reporter system, incubation time, and reference standards can change numerical results